
Precipio, Inc.
NASDAQ:PRPO
Overview | Financials
Company Name | Precipio, Inc. |
Symbol | PRPO |
Currency | USD |
Price | 4.5 |
Market Cap | 6,769,395 |
Dividend Yield | 0% |
52-week-range | 3.9 - 10.743 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Ilan Danieli |
Website | https://www.precipiodx.com |
About Precipio, Inc.
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD